# Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

> **NCT07333261** · PHASE1 · RECRUITING · sponsor: **Susan Bal** · enrollment: 25 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** BMS-986453

## Key facts

- **NCT ID:** NCT07333261
- **Lead sponsor:** Susan Bal
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-09
- **Primary completion:** 2031-12
- **Final completion:** 2041-12
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07333261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07333261, "Study of BMS-986453 in Newly Diagnosed Multiple Myeloma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07333261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*